Type 2 Diabetes Clinical Trial
Official title:
Comparison of Aerobic and Resistance Training Effects on Glycemic Control in Type 2 Diabetes
The purposes of this study are: a) to compare the effects of supervised programs of aerobic training or resistance training on the metabolic control of type 2 diabetes; b) to investigate some potential pathophysiologic and molecular mechanisms underlying these effects; c) to assess whether some changes may persist over time after termination of the supervised programs.
Meta-analyses of studies which evaluated the effects of interventions based upon structured
exercise programs in patients with type 2 diabetes show that regular physical activity may
improve glycosylated haemoglobin (HbA1c) by 0.6-0.7%. Most studies assessed the effects of
aerobic exercise. However, recent data suggest that resistance training may result in
similar effects. It seems likely that these beneficial results are obtained through
different molecular mechanisms by aerobic training and resistance training. Consequently,
these exercise modalities could be synergistic in improving the metabolic abnormalities in
these subjects. On the other hand, comparison data are very limited.
Aims of the protocol are to compare the effects of aerobic training or resistance training
on the metabolic control of type 2 diabetes and to investigate some potential
pathophysiologic and molecular mechanisms underlying these effects.
The study will be carried out in 40 sedentary type 2 diabetic patients without diabetic
complications, aged 40-70 yr, with body mass index (BMI) between 24-36 kg/m2 and HbA1c
between 6.5-9.0%. Admitted diabetes treatments will be diet and oral hypoglycemic agents.
Subjects will be assigned, by a randomization schedule weighted by baseline BMI and fitness,
to 2 groups of supervised exercise: aerobic training or resistance training. Training
programs will have a similar volume and will be scheduled in three 60 min sessions per week
for 4 months. During the study subjects will be instructed to follow an isocaloric diet.
Before and at the end of the exercise training the following will be assessed: HbA1c
(primary outcome), plasma glucose, lipid profile, blood pressure, insulin sensitivity
(glucose clamp), body composition (Dual energy X-ray absorptiometry, DEXA), liver and muscle
fat content (magnetic resonance imaging), expression in the muscle of some genes involved in
ATP production, mitochondrial biogenesis and substrate utilization, markers of inflammation,
oxidative stress and early vascular damage, peak oxygen uptake (VO2peak) during a maximal
exercise test, other exercise tests, tissue oxygen extraction during exercise (Near-infrared
spectroscopy, NIRS), energy expenditure and physical activity in daily life (metabolic
Holter and questionnaire). Monitoring of blood glucose will also be carried out over a 48h
period, comprising an exercise session (Continuous Glucose Monitoring System).
Metabolic features, exercise tests, body composition, daily physical activity and expression
of relevant genes in the muscle will also be assessed 1 yr after completion of the training
programs, to establish whether some changes may persist over time.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
| Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
| Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
| Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
| Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
| Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
| Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
| Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
| Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
| Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |